Companies: 10,795·Total market cap: $144.5T
Biofrontera AG

Biofrontera AG

BFFTFOTCHealthcare
$0.33
$-6.60(-95.24%)
Market Cap$19346895
P/E Ratio
52W High$22.68
52W Low$0.33

Biofrontera AG (BFFTF) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

bfftf · market cap & enterprise value · FMP · as of May 30, 2023

Core market cap & key metrics

As of May 30, 2023, Biofrontera AG (BFFTF) has a market cap — also referred to as its net worth or valuation — of $19,346,895, making it one of the top most valuable companies globally. Market Cap = $0.33 × shares outstanding.

Market Cap (Net Worth)$19,346,895bfftf market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0bfftf highest market cap ever
Stock Price$0.33OTC · May 30, 2023
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Biofrontera AG (BFFTF) has a market cap — also referred to as its net worth or valuation — of $19,346,895 as of May 30, 2023, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Biofrontera AG reached its all-time high market cap of $0 on —. Comparing the Biofrontera AG market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Biofrontera AG net worth vs peers and ask how Biofrontera AG valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

BFFTF market cap · 6 questions

Biofrontera AG's net worth — measured as market capitalization — is $19,346,895 as of May 30, 2023. It ranks #0 globally. Market Cap = $$0.33 (price) × shares outstanding.

BFFTF net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.